We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · April 21, 2021

Genome-Wide Meta-Analysis, Fine Mapping, and Integrative Prioritization Implicate New Alzheimer Risk Genes

Nature Genetics


Additional Info

Disclosure statements are available on the authors' profiles:

Nature Genetics
Genome-Wide Meta-Analysis, Fine-Mapping and Integrative Prioritization Implicate New Alzheimer's Disease Risk Genes
Nat. Genet 2021 Mar 01;53(3)392-402, J Schwartzentruber, S Cooper, JZ Liu, I Barrio-Hernandez, E Bello, N Kumasaka, AMH Young, RJM Franklin, T Johnson, K Estrada, DJ Gaffney, P Beltrao, A Bassett

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading